Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Trial Profile

Glargine Insulin Versus Continous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Feb 2016

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Apr 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 21 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top